Skip to search formSkip to main contentSkip to account menu

PRALMORELIN

Known as: Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2, D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, growth hormone-releasing peptide-2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The purpose of this study was to investigate an efficient synthetic route to the mono-PEGylated growth hormone releasing peptide… 
2009
2009
Castrated male pigs at 25 kg/BW were selected and fixed with jugular vein catheter.Eight pigs were divided into two groups of 4… 
Review
2004
Review
2004
Pralmorelin [GPA 748, GHRP 2, growth hormone-releasing peptide 2, KP-102 D, KP 102 LN] is an orally active, synthetic growth… 
2004
2004
(GHRP-1, -2, -6 and hexarelin, 100 μg:kg -1 SC BID) treatment for 3 weeks are studied. Plasma nonepinephrine, renin, angiotencin… 
2003
2003
Negative feedback on GH responses to GH-releasing hormone (GHRH) and GH-releasing peptides (GHRPs) has been reported and this… 
Review
2002
Review
2002
Growth hormone-releasing peptide-2 (GHRP-2, also named KP102) is a new hexapeptide of a series of synthetic growth hormone… 
2002
2002
It is still controversial in rat whether the stimulation of GH secretion by GH-releasing peptides (GHRP) requires both GHRP…